Detrimental dermal wound healing: What can we learn from the oral mucosa?

Wound Repair and Regeneration

Volumn 21, Issue 5, 2013, Pages 648-660

  Glim, Judith E ^a   Van Egmond, Marjolein ^a   Niessen, Frank B ^a   Everts, Vincent ^b   Beelen, Robert H J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CONNECTIVE TISSUE GROWTH FACTOR; CXCL3 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN 24; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN; PROCOLLAGEN TYPE 1; PROSTAGLANDIN E2; RANTES; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BLOOD VESSEL; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; EPITHELIZATION; EXTRACELLULAR MATRIX; FIBROBLAST; HISTOLOGY; HUMAN; IMMUNOCOMPETENT CELL; KERATINOCYTE; MACROPHAGE; MAST CELL; MESENCHYMAL STEM CELL; MOUTH LESION; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SALIVA; SCAR FORMATION; SKIN INJURY; SKIN SCAR; WOUND HEALING;

ACTINS; ANIMALS; CICATRIX; COLLAGEN TYPE I; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; INFLAMMATION; KERATINOCYTES; MICE; MOUTH MUCOSA; SALIVA; SKIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84883490630     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12072     Document Type: Review

References (117)

1. Bock O, Schmid-Ott G, Malewski P, Mrowietz U,. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006; 297: 433-438.
2. Slemp AE, Kirschner RE,. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006; 18: 396-402.
3. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB,. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999; 277 (1 Pt 1): C1-C9.
4. Pellegrin S, Mellor H,. Actin stress fibres. J Cell Sci 2007; 120 (Pt;%20): 3491-3499.
5. Wulff BC, Parent AE, Meleski MA, Dipietro LA, Schrementi ME, Wilgus TA,. Mast cells contribute to scar formation during fetal wound healing. J Invest Dermatol 2012; 312: 458-465.
6. Liechty KW, Kim HB, Adzick NS, Crombleholme TM,. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg 2000; 35: 866-872.
7. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW, et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 2008; 128: 1852-1860.
8. Favata M, Beredjiklian PK, Zgonis MH, Beason DP, Crombleholme TM, Jawad AF, et al. Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment. J Orthop Res 2006; 24: 2124-2132.
9. Longaker MT, Whitby DJ, Ferguson MW, Lorenz HP, Harrison MR, Adzick NS,. Adult skin wounds in the fetal environment heal with scar formation. Ann Surg 1994; 219: 65-72.
10. Coolen NA, Schouten KC, Middelkoop E, Ulrich MM,. Comparison between human fetal and adult skin. Arch Dermatol Res 2010; 302: 47-55.
11. Whitby DJ, Ferguson MW,. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 1991; 112: 651-668.
12. Knight KR, Horne RS, Lepore DA, Kumta S, Ritz M, Hurley JV, et al. Glycosaminoglycan composition of uninjured skin and of scar tissue in fetal, newborn and adult sheep. Res Exp Med (Berl) 1994; 194: 119-127.
13. Chen W, Fu X, Ge S, Sun T, Zhou G, Jiang D, et al. Ontogeny of expression of transforming growth factor-beta and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair Regen 2005; 13: 68-75.
14. Coolen NA, Schouten KC, Boekema BK, Middelkoop E, Ulrich MM,. Wound healing in a fetal, adult, and scar tissue model: a comparative study. Wound Repair Regen 2010; 18: 291-301.
15. Larjava H, Wiebe C, Gallant-Behm C, Hart DA, Heino J, Hakkinen L,. Exploring scarless healing of oral soft tissues. J Can Dent Assoc 2011; 77: b18.
16. Wijdeveld MG, Maltha JC, Grupping EM, De JJ, Kuijpers-Jagtman AM,. A histological study of tissue response to simulated cleft palate surgery at different ages in beagle dogs. Arch Oral Biol 1991; 36: 837-843.
17. Kanitakis J,. Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol 2002; 12: 390-399.
18. Marieb EN, Mallat J,. Human anatomy. Menlo Park, CA: Benjamin/Cummings, 1997.
19. Smart JD,. Lectin-mediated drug delivery in the oral cavity. Adv Drug Deliv Rev 2004; 56: 481-489.
20. Sonis ST,. The pathobiology of mucositis. Nat Rev Cancer 2004; 4: 277-284.
21. Liu J, Bian Z, Kuijpers-Jagtman AM, Von den Hoff JW,. Skin and oral mucosa equivalents: construction and performance. Orthod Craniofac Res 2010; 13: 11-20.
22. Squier CA, Kremer MJ,. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001; 29: 7-15.
23. Hsieh PC, Jin YT, Chang CW, Huang CC, Liao SC, Yuan K,. Elastin in oral connective tissue modulates the keratinization of overlying epithelium. J Clin Periodontol 2010; 37: 705-711.
24. Wong JW, Gallant-Behm C, Wiebe C, Mak K, Hart DA, Larjava H, et al. Wound healing in oral mucosa results in reduced scar formation as compared with skin: evidence from the red Duroc pig model and humans. Wound Repair Regen 2009; 17: 717-729.
25. Li J, Farthing PM, Ireland GW, Thornhill MH,. IL-1 alpha and IL-6 production by oral and skin keratinocytes: similarities and differences in response to cytokine treatment in vitro. J Oral Pathol Med 1996; 25: 157-162.
26. Li J, Ireland GW, Farthing PM, Thornhill MH,. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996; 106: 661-666.
27. Szpaderska AM, Zuckerman JD, Dipietro LA,. Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 2003; 82: 621-626.
28. Schrementi ME, Ferreira AM, Zender C, Dipietro LA,. Site-specific production of TGF-beta in oral mucosal and cutaneous wounds. Wound Repair Regen 2008; 16: 80-86.
29. Ishida Y, Kimura A, Kuninaka Y, Inui M, Matsushima K, Mukaida N, et al. Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing. J Clin Invest 2012; 122: 711-721.
30. Suh W, Kim KL, Kim JM, Shin IS, Lee YS, Lee JY, et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005; 23: 1571-1578.
31. Stavenuiter AW, Schilte MN, Ter Wee PM, Beelen RH,. Angiogenesis in peritoneal dialysis. Kidney Blood Press Res 2011; 34: 245-252.
32. van der Veer W, Niessen FB, Ferreira JA, Zwiers PJ, de Jong EH, Middelkoop E, et al. Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans. Wound Repair Regen 2011; 19: 292-301.
33. Mak K, Manji A, Gallant-Behm C, Wiebe C, Hart DA, Larjava H, et al. Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model. J Dermatol Sci 2009; 56: 168-180.
34. Szpaderska AM, Walsh CG, Steinberg MJ, Dipietro LA,. Distinct patterns of angiogenesis in oral and skin wounds. J Dent Res 2005; 84: 309-314.
35. Ricard-Blum S,. The collagen family. Cold Spring Harb Perspect Biol 2011; 3: a004978.
36. Bosman FT, Stamenkovic I,. Functional structure and composition of the extracellular matrix. J Pathol 2003; 200: 423-428.
37. Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, et al. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 2003; 162: 149-160.
38. Muro AF, Moretti FA, Moore BB, Yan M, Atrasz RG, Wilke CA, et al. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177: 638-645.
39. Sumioka T, Kitano A, Flanders KC, Okada Y, Yamanaka O, Fujita N, et al. Impaired cornea wound healing in a tenascin C-deficient mouse model. Lab Invest 2013; 93: 207-217.
40. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999; 274: 25085-25092.
41. Ghazi K, Deng-Pichon U, Warnet JM, Rat P,. Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS ONE 2012; 7: e48351.
42. Yamada Y, Itano N, Hata K, Ueda M, Kimata K,. Differential regulation by IL-1beta and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: quantitative analysis using real-time RT-PCR. J Invest Dermatol 2004; 122: 631-639.
43. Meran S, Thomas D, Stephens P, Martin J, Bowen T, Phillips A, et al. Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol Chem 2007; 282: 25687-25697.
44. Irwin CR, Picardo M, Ellis I, Sloan P, Grey A, McGurk M, et al. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing. J Cell Sci 1994; 107 (Pt 5): 1333-1346.
45. Pedlar J,. Biochemistry of glycosaminoglycans in the skin and oral mucosa of the rat. Arch Oral Biol 1984; 29: 591-597.
46. Amalinei C, Caruntu ID, Balan RA,. Biology of metalloproteinases. Rom J Morphol Embryol 2007; 48: 323-334.
47. Dang CM, Beanes SR, Lee H, Zhang X, Soo C, Ting K,. Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue-derived inhibitor of metalloproteinase ratio. Plast Reconstr Surg 2003; 111: 2273-2285.
48. Simon F, Bergeron D, Larochelle S, Lopez-Valle CA, Genest H, Armour A, et al. Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis. Burns 2012; 38: 421-427.
49. McKeown ST, Barnes JJ, Hyland PL, Lundy FT, Fray MJ, Irwin CR,. Matrix metalloproteinase-3 differences in oral and skin fibroblasts. J Dent Res 2007; 86: 457-462.
50. Shannon DB, McKeown ST, Lundy FT, Irwin CR,. Phenotypic differences between oral and skin fibroblasts in wound contraction and growth factor expression. Wound Repair Regen 2006; 14: 172-178.
51. Stephens P, Davies KJ, Occleston N, Pleass RD, Kon C, Daniels J, et al. Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br J Dermatol 2001; 144: 229-237.
52. Ebisawa K, Kato R, Okada M, Sugimura T, Latif MA, Hori Y, et al. Gingival and dermal fibroblasts: their similarities and differences revealed from gene expression. J Biosci Bioeng 2011; 111: 255-258.
53. Martins VL, Caley M, O'Toole EA,. Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res 2013; 351: 255-268.
54. Epstein JB, Scully C,. The role of saliva in oral health and the causes and effects of xerostomia. J Can Dent Assoc 1992; 58: 217-221.
55. Dayan D, Bodner L, Horowitz I,. Effect of salivary gland hypofunction on the healing of extraction wounds: a histomorphometric study in rats. J Oral Maxillofac Surg 1992; 50: 354-358.
56. Oudhoff MJ, van den Keijbus PA, Kroeze KL, Nazmi K, Gibbs S, Bolscher JG, et al. Histatins enhance wound closure with oral and non-oral cells. J Dent Res 2009; 88: 846-850.
57. Groschl M, Topf HG, Kratzsch J, Dotsch J, Rascher W, Rauh M,. Salivary leptin induces increased expression of growth factors in oral keratinocytes. J Mol Endocrinol 2005; 34: 353-366.
58. Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J,. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000; 106: 501-509.
59. Kesting MR, Mueller C, Wagenpfeil S, Stoeckelhuber M, Steiner T, Bauer F, et al. Quantitative comparison of the expression of antimicrobial peptides in the oral mucosa and extraoral skin. Br J Oral Maxillofac Surg 2012; 50: 447-453.
60. Gailit J, Marchese MJ, Kew RR, Gruber BL,. The differentiation and function of myofibroblasts is regulated by mast cell mediators. J Invest Dermatol 2001; 117: 1113-1119.
61. Kischer CW, Bunce H, III, Shetlah MR,. Mast cell analyses in hypertrophic scars, hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 1978; 70: 355-357.
62. Gallant-Behm CL, Hildebrand KA, Hart DA,. The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs. Wound Repair Regen 2008; 16: 226-233.
63. Deng Q, Harvie EA, Huttenlocher A,. Distinct signaling mechanisms mediate neutrophil attraction to bacterial infection and tissue injury. Cell Microbiol 2012; 14: 517-528.
64. Ma Y, Kleinbeck K, Kao WJ,. Extracellular matrix-derived tripeptide proline-glycine-proline inhibits keratinocyte proliferation and migration. Wound Repair Regen 2011; 19: 718-726.
65. Costa RA, Ruiz-de-Souza V, Azevedo GM, Jr, Gava E, Kitten GT, Vaz NM, et al. Indirect effects of oral tolerance improve wound healing in skin. Wound Repair Regen 2011; 19: 487-497.
66. Mosser DM, Edwards JP,. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
67. Deonarine K, Panelli MC, Stashower ME, Jin P, Smith K, Slade HB, et al. Gene expression profiling of cutaneous wound healing. J Transl Med 2007; 5: 11.- 11.
68. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3. Scand J Immunol 2001; 53: 386-392.
69. Gratchev A, Kzhyshkowska J, Utikal J, Goerdt S,. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand J Immunol 2005; 61: 10-17.
70. Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS,. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000; 204: 19-28.
71. Glim JE, Niessen FB, Everts V, van Egmond M, Beelen RH,. Platelet derived growth factor-CC secreted by M2 macrophages induces alpha-smooth muscle actin expression by dermal and gingival fibroblasts. Immunobiology 2013; 218: 924-929.
72. Goren I, Allmann N, Yogev N, Schurmann C, Linke A, Holdener M, et al. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol 2009; 175: 132-147.
73. Mirza R, Dipietro LA, Koh TJ,. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009; 175: 2454-2462.
74. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010; 184: 3964-3977.
75. Fishel RS, Barbul A, Beschorner WE, Wasserkrug HL, Efron G,. Lymphocyte participation in wound healing. Morphologic assessment using monoclonal antibodies. Ann Surg 1987; 206: 25-29.
76. Wang J, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE,. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen 2007; 15: 530-539.
77. Toulon A, Breton L, Taylor KR, Tenenhaus M, Bhavsar D, Lanigan C, et al. A role for human skin-resident T cells in wound healing. J Exp Med 2009; 206: 743-750.
78. Jameson J, Ugarte K, Chen N, Yachi P, Fuchs E, Boismenu R, et al. A role for skin γδ T cells in wound repair. Science 2002; 296: 747-749.
79. Wang J, Hori K, Ding J, Huang Y, Kwan P, Ladak A, et al. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 2011; 226: 1265-1273.
80. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N,. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-κB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 2006; 176: 5598-5606.
81. Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N,. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 2003; 73: 713-721.
82. Graves DT, Nooh N, Gillen T, Davey M, Patel S, Cottrell D, et al. IL-1 plays a critical role in oral, but not dermal, wound healing. J Immunol 2001; 167: 5316-5320.
83. Graves DT, Chen CP, Douville C, Jiang Y,. Interleukin-1 receptor signaling rather than that of tumor necrosis factor is critical in protecting the host from the severe consequences of a polymicrobe anaerobic infection. Infect Immun 2000; 68: 4746-4751.
84. Chen L, Arbieva ZH, Guo S, Marucha PT, Mustoe TA, Dipietro LA,. Positional differences in the wound transcriptome of skin and oral mucosa. BMC Genomics 2010; 11: 471.
85. Eitner F, Bucher E, van Roeyen C, Kunter U, Rong S, Seikrit C, et al. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J Am Soc Nephrol 2008; 19: 281-289.
86. Liu S, Shi-wen X, Abraham DJ, Leask A,. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum 2011; 63: 239-246.
87. Sisco M, Kryger ZB, O'Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, et al. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair Regen 2008; 16: 661-673.
88. Dransfield DT, Cohen EH, Chang Q, Sparrow LG, Bentley JD, Dolezal O, et al. A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo. Mol Cancer Ther 2010; 9: 1809-1819.
89. Hsu E, Feghali-Bostwick CA,. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol 2008; 172: 1580-1590.
90. Verrecchia F, Mauviel A,. Transforming growth factor-beta and fibrosis. World J Gastroenterol 2007; 13: 3056-3062.
91. Annes JP, Munger JS, Rifkin DB,. Making sense of latent TGFβ activation. J Cell Sci 2003; 116 (Pt 2): 217-224.
92. Wang R, Ghahary A, Shen Q, Scott PG, Roy K, Tredget EE,. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 2000; 8: 128-137.
93. Tredget EE, Yang L, Delehanty M, Shankowsky H, Scott PG,. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 2006; 26: 179-189.
94. Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N,. The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process. J Immunol 2004; 172: 1848-1855.
95. Harrop AR, Ghahary A, Scott PG, Forsyth N, Uji-Friedland A, Tredget EE,. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. J Surg Res 1995; 58: 471-477.
96. Larrabee WF Jr, East CA, Jaffe HS, Stephenson C, Peterson KE,. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990; 116: 1159-1162.
97. Angelov N, Moutsopoulos N, Jeong MJ, Nares S, Ashcroft G, Wahl SM,. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor. Thromb Haemost 2004; 92: 288-297.
98. Eslami A, Gallant-Behm CL, Hart DA, Wiebe C, Honardoust D, Gardner H, et al. Expression of integrin αvβ6 and TGF-β in scarless vs scar-forming wound healing. J Histochem Cytochem 2009; 57: 543-557.
99. Meran S, Thomas DW, Stephens P, Enoch S, Martin J, Steadman R, et al. Hyaluronan facilitates transforming growth factor-β1-mediated fibroblast proliferation. J Biol Chem 2008; 283: 6530-6545.
100. Wilgus TA,. Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol Res 2008; 58: 112-116.
101. Lee HG, Eun HC,. Differences between fibroblasts cultured from oral mucosa and normal skin: implication to wound healing. J Dermatol Sci 1999; 21: 176-182.
102. Gron B, Stoltze K, Andersson A, Dabelsteen E,. Oral fibroblasts produce more HGF and KGF than skin fibroblasts in response to co-culture with keratinocytes. APMIS 2002; 110: 892-898.
103. Stephens P, Hiscox S, Cook H, Jiang WG, Zhiquiang W, Thomas DW,. Phenotypic variation in the production of bioactive hepatocyte growth factor/scatter factor by oral mucosal and skin fibroblasts. Wound Repair Regen 2001; 9: 34-43.
104. Okazaki M, Yoshimura K, Uchida G, Harii K,. Elevated expression of hepatocyte and keratinocyte growth factor in cultured buccal-mucosa-derived fibroblasts compared with normal-skin-derived fibroblasts. J Dermatol Sci 2002; 30: 108-115.
105. Grose R, Werner S,. Wound-healing studies in transgenic and knockout mice. Mol Biotechnol 2004; 28: 147-166.
106. Lygoe KA, Wall I, Stephens P, Lewis MP,. Role of vitronectin and fibronectin receptors in oral mucosal and dermal myofibroblast differentiation. Biol Cell 2007; 99: 601-614.
107. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
108. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004; 22: 377-384.
109. Nauta A, Gurtner G, Longaker MT,. Wound healing and regenerative strategies. Oral Dis 2011; 17: 541-549.
110. Stephens P, Genever P,. Non-epithelial oral mucosal progenitor cell populations. Oral Dis 2007; 13: 1-10.
111. Hocking AM, Gibran NS,. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res 2010; 316: 2213-2219.
112. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009; 175: 303-313.
113. Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Shi S, et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 2009; 183: 7787-7798.
114. Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, Wong A, et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 2010; 28: 1856-1868.
115. Ylostalo JH, Bartosh TJ, Coble K, Prockop DJ,. Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 2012; 30: 2283-2296.
116. Tomar GB, Srivastava RK, Gupta N, Barhanpurkar AP, Pote ST, Jhaveri HM, et al. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun 2010; 393: 377-383.
117. Verstappen J, van Rheden RE, Katsaros C, Torensma R, Von den Hoff JW,. Preferential recruitment of bone marrow-derived cells to rat palatal wounds but not to skin wounds. Arch Oral Biol 2012; 57: 102-108.